Eli Lilly takes weight-loss pill battle global with first Foundayo approval outside U.S.CNBC • 08/11/26
17 S&P 500 companies with growing revenue and profit margins — and some of their stocks are cheapMarket Watch • 08/10/26
Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a ProblemThe Motley Fool • 08/07/26
Eli Lilly: 'Strong Buy' On Retatrutide Obesity Drug And EBGLYSS Maintenance Label ExpansionSeeking Alpha • 08/07/26
3 Medical Stocks Standing Out After Crushing Q2 Earnings ExpectationsZacks Investment Research • 08/06/26